Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.340
-0.060 (-4.29%)
At close: Jun 13, 2025, 4:00 PM
1.330
-0.010 (-0.74%)
After-hours: Jun 13, 2025, 7:07 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $293.10 million as of June 13, 2025. Its market cap has decreased by -39.75% in one year.

Market Cap
293.10M
Enterprise Value
101.98M
1-Year Change
-39.75%
Ranking
Category
Stock Price
$1.34

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax17 Jun 202013 Jun 2025Max ▾Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '2501,000M2,000M3,000M4,000M5,000M6,000M293M

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $293.10M, a decrease of -89.83%. That is a compound annual growth rate of -28.98%.

History

DateMarket Cap% Change
Jun 13, 2025293.10M-34.37%
Dec 31, 2024446.60M-17.32%
Dec 29, 2023540.17M-40.45%
Dec 30, 2022907.08M-57.34%
Dec 31, 20212.13B-39.95%
Dec 31, 20203.54B11.80%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.57B
Johnson & Johnson 377.99B
Novo Nordisk 355.28B
AbbVie 337.52B
UnitedHealth Group 284.42B
Abbott Laboratories 235.96B
Novartis AG 234.52B
AstraZeneca 231.58B
Market Cap Rankings